AU629799B2 - Prosthesis-fixing cement-forming composition containing cell growth stimulant - Google Patents

Prosthesis-fixing cement-forming composition containing cell growth stimulant Download PDF

Info

Publication number
AU629799B2
AU629799B2 AU26160/88A AU2616088A AU629799B2 AU 629799 B2 AU629799 B2 AU 629799B2 AU 26160/88 A AU26160/88 A AU 26160/88A AU 2616088 A AU2616088 A AU 2616088A AU 629799 B2 AU629799 B2 AU 629799B2
Authority
AU
Australia
Prior art keywords
prosthesis
cement
composition according
cell growth
forming composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU26160/88A
Other versions
AU2616088A (en
Inventor
Sandra Downes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2616088A publication Critical patent/AU2616088A/en
Assigned to DOWNES, SANDRA reassignment DOWNES, SANDRA Alteration of Name(s) of Applicant(s) under S113 Assignors: NOVO NORDISK A/S
Application granted granted Critical
Publication of AU629799B2 publication Critical patent/AU629799B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
    • A61B17/8802—Equipment for handling bone cement or other fluid fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2002/4631—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor the prosthesis being specially adapted for being cemented
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A61L2300/222—Steroids, e.g. corticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

-i: -r OPI DATE 23/05/89 WO AOJP DATE 29/06/89 APPLN- ID 26160 88 PCT NUMBER PCT/DK88/00170
PU'
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (51) International Patent Classification 4 (11) International Publication Number: WO 89/ 03695 A61L 25/00, A61K 37/36 A l (43) International Publication Date: 5 May 1989 (05.05.89) (21) International Application Number: PCT/DK88/00170 (22) International Filing Date: 24 October 1988 (24.10.88) (31) Priority Application Number: 8724897 (32) Priority Date: 23 October 1987 (23.10.87) (81) Designated States: AT (European patent), AU, BE (European patent), CH (European patent), DE (European patent), DK, FI, FR (European patent), GB (European patent), HU, IT (European patent), JP, LU (European patent), NL (European patent), NO, SE (European patent), SU, US.
Publised,_ Scior 4 I)e.r 4 s. W-OZ LAGr (33) F'3 (71) (72) ECTION 113 DIRECTION SEE FOLIO AME DIRECTED f rV C tIrv o.
F)rotF) -oDm 'LJ I13 S e [Lu7r/GBl7 4MTnrway, tusney, warrora, renrs. vwj 2AG (GB).
(74) Agent: HOFMAN-BANG BOUTARD A/S: Adelgade 15, DK-1304 Copenhagen K (DK).
629799 629799 (54) Title: "Prosthesis-Fixing Cement-Forming Composition Containing Cell Growth Stimulant".
(57) Abstract A bone cement, comprising a physiologically acceptable reaction resin, such as a PMMA casting resin mixture, and a cell growth stimulant, such as human growth hormone, is useful for healing bone fractures and repairing bone defects.
The cement will promote bone cell formation and give joints having increased strength.
L_ IIIIL~
K:
,~fr COMMONWEALTH OF AUSTRALIA 'atlents Act DF.CLARATION FOR A PATENT APPLICATION
TINSTRUCTIONS
Insert .Convention" if app Iicable Insert FULL name(s) of applicant(s) Insert "of addition" if applicablc Insert TITLE of invention Insert FULL namne(s) AND address(es) of declarant(s) (See lteadnotei.) In support of the convention NO'JO-NORDISK A/S Novo A116 DK-2880 Bagsvmrd application made by Denmark (hereinafter called "applicant(s)") for a patent (c) invention entitled 8one cement including a cell growith stimulant for an 0 O* A I.
actuu nvn1or(s) 00.
Recite 1o0e applicn(s) :criv'elsl title fromt actual investorfs) Se lneadivotc* can I I/M e I) P. Eisten Pettersson of Novo A116, DK-2880 Bagsvwrd Head of Department Patent Department do solemnly and sincerely declare as follows: (or, in tihe case of an application by a body corporate) I.Iam/Y0%x*W authorized to make this declaration on behalf of the applicant().
2. x j x p~- (or, where tile applicant(s) is/are not the actual inventor(s) 2. M Sandra Dowsnes 74 Mill Way Bushey, Watford Herts. WD2 2AG E ngI1 an d is/xiiethe actual inventor(., of the invention and the facts upon which the applicant4 is/*M~Centitled to make the application are as follows: Applicant is the assignee of the invention from the said actual inventor se ki) Insert country.
filing date, and bausic applteantlel basic lpplication (Note: Paragraphs 3 and 4 apply only to Convention applications) 3. The basic application(N) for patent or similar protection on which the application is based is/am~ identified by country, filing date, and basic applicant(a) as follows: (Is) Great Britain October 23, 1987 Sandra Downes 4. The basic application6 referred to in paragraph 3 hereof was/%mthe first applicatiotiM made in a Convention country in respect of the invention the subject of the application.
Wk Insert PLACE of signing Inscrt DATE of signing (tIn) Signaturefs) of declarantta) Nalet No legalization or othesr witness required Declared at Wie Dated (1) Bagsva'rd April 18, 1990 P. Eisten Pettersson V k To: The Comimissioner of Pqtents

Claims (4)

1. A cement-forming composition for use in particular in prosthesis fixing and which comprises a reaction resin and a growth hormone, characterised by the incorporation of a cell growth stimulant selected from somatotrophins, somatedins, parathyroid hormone (PTH) and sex steroids in a physiologically reaction resin which, as a cured material, provides a delivery system for delivery of the coll growth stimulant over an extended period of time to a bone surface at which the prosthesis is to be secured.
2. A cement composition according to Claim 1, wherein the cell growth stimulant is a somatotrophin which is human growth hormone (hGH).
3. A cement composition according to Claim 1 or 2, which comprises a reaction resin in fluid, semi- liquid dough-like or mouldable form able to cure in situ at a temperature of from 30 to 45 0 C and at a 20 location at which a prosthesis is to be secured.
4. A cement composition according to Claim 2, or Claims 2 and 3 together which comprises a) a monomeric acrylic compound and b) a mixture of powdered polymethacrylate and human growth hormone such that there is provided a system for delivery of the human S.:i growth hormone over an extended period of time to a bone surface at which the prosthesis is to be secured. A cement forming composition according to claim i substantially as hereinbefore described with reference to any one of the Examples. DATED 17 August, 1992. PHILLIPS ORMONDE FITZPATRICK ATTORNEYS FOR: SANDRA DOWNES 9i UTL
AU26160/88A 1987-10-23 1988-10-24 Prosthesis-fixing cement-forming composition containing cell growth stimulant Ceased AU629799B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878724897A GB8724897D0 (en) 1987-10-23 1987-10-23 Material
GB8724897 1987-10-23

Publications (2)

Publication Number Publication Date
AU2616088A AU2616088A (en) 1989-05-23
AU629799B2 true AU629799B2 (en) 1992-10-15

Family

ID=10625798

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26160/88A Ceased AU629799B2 (en) 1987-10-23 1988-10-24 Prosthesis-fixing cement-forming composition containing cell growth stimulant

Country Status (6)

Country Link
EP (1) EP0386056A1 (en)
JP (1) JPH03505406A (en)
AU (1) AU629799B2 (en)
FI (1) FI902042A0 (en)
GB (1) GB8724897D0 (en)
WO (1) WO1989003695A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011195A1 (en) * 1990-02-02 1991-08-08 Novo Nordisk A/S A method of treating a mammal with a biologically active compound
WO1991011196A1 (en) * 1990-02-02 1991-08-08 Novo Nordisk A/S A method of treating a mammal with a biologically active compound
DK27390D0 (en) * 1990-02-02 1990-02-02 Troels Torp Andreassen METHOD AND APPARATUS FOR ADMINISTRATING BIOLOGICALLY ACTIVE SUBSTANCES
GB2261672A (en) * 1991-11-18 1993-05-26 Michael Braden The use of biomaterials for tissue repair
EP0941115A1 (en) * 1996-11-05 1999-09-15 Novo Nordisk A/S Use of growth hormone or a growth hormone secretagogue for promoting bone formation
SE9900519D0 (en) 1999-02-17 1999-02-17 Lars Lidgren A method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof
KR100365678B1 (en) * 2000-03-24 2002-12-26 주식회사 엘지생명과학 The somatotropin formulation of improved syringeability
SE520688C2 (en) * 2000-04-11 2003-08-12 Bone Support Ab An injectable bone mineral replacement material
SE517168C2 (en) 2000-07-17 2002-04-23 Bone Support Ab A composition for an injectable bone mineral replacement material
EP1767213A3 (en) * 2001-11-05 2007-04-25 Eli Lilly & Company Method for improving stability of a bone-connecting implant
AU2002363412A1 (en) * 2001-11-05 2003-05-19 Eli Lilly And Company Method for improving stability of a bone-connecting implant
CH695985A5 (en) * 2002-01-21 2006-11-15 Straumann Holding Ag Surface-modified implants.
DE10305810A1 (en) * 2003-02-12 2004-08-26 Ethicon Gmbh Osteo-inductive bone filling material, comprises matrix containing anabolic steroid to accelerate bone growth and healing
SE0302983D0 (en) 2003-11-11 2003-11-11 Bone Support Ab Apparatus for providing spongy bone with bone replacement and / or bone strengthening material and associated method
SE527528C2 (en) 2004-06-22 2006-04-04 Bone Support Ab Apparatus for the preparation of curable pulp and use of the apparatus
CN101663043B (en) * 2007-04-27 2014-03-12 尤尼基因实验室公司 Methods and compositions for fostering and preserving bone growth
US8821504B2 (en) 2009-11-20 2014-09-02 Zimmer Knee Creations, Inc. Method for treating joint pain and associated instruments
US8951261B2 (en) * 2009-11-20 2015-02-10 Zimmer Knee Creations, Inc. Subchondral treatment of joint pain
US9180137B2 (en) 2010-02-09 2015-11-10 Bone Support Ab Preparation of bone cement compositions
AU2014220664B2 (en) 2013-02-20 2017-10-05 Bone Support Ab Improved setting of hardenable bone substitute

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0198213A2 (en) * 1985-03-15 1986-10-22 Yeda Research And Development Company, Ltd. Method and compositions comprising a vitamin D derivative for the local treatment of bone fractures
AU583558B2 (en) * 1984-10-16 1989-05-04 Ferring Laboratories, Inc. Cold-curing bone cement

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526909A (en) * 1984-01-09 1985-07-02 Regents Of The University Of California Polymethylmethacrylate delivery system for bone morphogenetic protein
US4620327A (en) * 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU583558B2 (en) * 1984-10-16 1989-05-04 Ferring Laboratories, Inc. Cold-curing bone cement
EP0198213A2 (en) * 1985-03-15 1986-10-22 Yeda Research And Development Company, Ltd. Method and compositions comprising a vitamin D derivative for the local treatment of bone fractures
AU581735B2 (en) * 1985-03-15 1989-03-02 Yeda Research And Development Co. Ltd. Method and compositions comprising a vitamin D derivative for the local treatment of bone fractures

Also Published As

Publication number Publication date
JPH03505406A (en) 1991-11-28
EP0386056A1 (en) 1990-09-12
FI902042A0 (en) 1990-04-23
WO1989003695A1 (en) 1989-05-05
GB8724897D0 (en) 1987-11-25
AU2616088A (en) 1989-05-23

Similar Documents

Publication Publication Date Title
AU629799B2 (en) Prosthesis-fixing cement-forming composition containing cell growth stimulant
EP0205997B1 (en) Implant
ATE418563T1 (en) NIK PROTEINS, NUCLEIC ACID AND METHODS
CA2220871A1 (en) Peptide/protein suspending formulations
DE69520149D1 (en) TIE-2 LIGANDE, METHOD FOR THEIR PRODUCTION, AND THEIR APPLICATIONS
BR9916863A (en) Compositions containing rheological modifiers with polymers containing functional group
DE3476077D1 (en) Transparent anti-fog coating compositions
ATE266471T1 (en) METAL MIXED CATALYST COMPOSITION, PRODUCTION AND USE THEREOF
IL117144A0 (en) Pharmaceutical compositions containing nucleic acids
IL180906A0 (en) Pharmaceutical compositions comprising chromium and biotin and such pharmaceutical composition for reducing hyperglycemia and stabilizing the level of serum glucose
CA2280290A1 (en) Netrin receptors
EE200000039A (en) Use of MHC Class II Ligand, Pharmaceutical Composition, Transfected Tumor Cells, Method of Preparing Transfected Cells and Tumor Cells, and Their Use
BR0010940A (en) Coating material with a mixture of at least one wetting agent and urea and / or urea derivatives as thixotropic agents
DE59901084D1 (en) METHOD FOR SEALING POROUS BUILDING MATERIALS AND COMPONENTS
WO2001023521A3 (en) Polypeptide derivatives of parathyroid hormone (PTH)
BR9809785A (en) Calcitonin receptor binding compound, reagent, scintigraphic imaging agent, composition, radio-therapeutic agent, complex, kit for preparing a radio-pharmaceutical preparation, processes for labeling the reagent, for making the reagent, and, use of reagent
EP0992584A3 (en) Purified mammalian FLT3 ligands and agonists and antagonists thereof
EP0283407A3 (en) Heat-vulcanizable elastomeric silicon composition containing iodide
JP3323072B2 (en) Epoxy resin composition
DE69736158D1 (en) Glutamine: fructose-6-phosphate amidotransferase (GFAT), its preparation and use
FR2717465B1 (en) Injection grout to coat a reinforcement, in particular a prestressing reinforcement.
BR9915431A (en) Cathodic electrocoating coating composition
DE69014152D1 (en) Process for the preparation of tigogenin beta cellobiosides.
US8481010B2 (en) Covalently bonding nail primer
JP2000014763A (en) Bioactive cement composition